Hepatitis C worldwide and in Brazil: Silent epidemic - Data on disease including incidence, transmission, prevention, and treatment

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Kretzer, Iara Fabricia ^a   Livramento, Andrea Do ^a   Cunha, Joel Da ^b   Gonçalves, Sabrina ^a   Tosin, Iraci ^a   Spada, Celso ^a   Treitinger, Aricio ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BOCEPREVIR; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN; TELAPREVIR;

AFRICA; AFRICA SOUTH OF THE SAHARA; ARGENTINA; AUSTRALIA AND NEW ZEALAND; BRAZIL; CANADA; CENTRAL AFRICA; CHINA; CZECH REPUBLIC; DISEASE TRANSMISSION; EGYPT; EPIDEMIC; FEDERATED STATES OF MICRONESIA; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; GREECE; HEALTH EDUCATION; HEPATITIS C; HUMAN; HUNGARY; INCIDENCE; INDIA; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; ITALY; MELANESIA; MEXICO; NORWAY; PAKISTAN; PERU; POLAND; POLYNESIA; PORTUGAL; PREVALENCE; PRIMARY PREVENTION; PUERTO RICO; REVIEW; ROMANIA; RURAL AREA; RUSSIAN FEDERATION; SECONDARY PREVENTION; SPAIN; SWEDEN; SWITZERLAND; TAIWAN; UNITED KINGDOM; UNITED STATES; URBAN POPULATION; VENEZUELA; VIET NAM; TRANSMISSION;

BRAZIL; HEPATITIS C; HUMANS;

EID: 84903643207     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/827849     Document Type: Review

References (76)

1. World Health Organization, Hepatitis C 2013 Fact sheet no. 164 Geneva, Switzerland World Health OrganizationMedia Centre Hepatitis C key facts. http://www.who.int/mediacentre/factsheets/fs164/en/index.html
2. World Health Organization, Prevention and Control of Viral Hepatitis Infection: Framework for Global Action 2012 Geneva, Switzerland World Health Organization. http://www.who.int/csr/disease/hepatitis/Framework/en/
3. Terrault N. A., Sexual activity as a risk factor for hepatitis C. Hepatology 2002 36 5 S99 S105 2-s2.0-0036830437 10.1053/jhep.2002.36797 (Pubitemid 35253469)
4. Brazilian Institute of Geography and Statistics, Maps of Brazil: Political Map 2014 Brasília, Brazil IBGE. Digital School Geographic Atlas, 2014 (Portuguese), http://atlasescolar.ibge.gov.br/images/atlas/mapas- brasil/brasil-politico.pdf
5. Brazil Ministry of Health, 2012 Epidemiological Bulletin on Viral Hepatitis 2012 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/sites/default/files/anexos/publicacao/2012/51820/ boletim-epidemiol-gico-hepatites-virais-2012-ve-12026.pdf
6. Brazilian Institute of Geography and Statistics, 2010 Population Census Summary Brasília, Brazil IBGE. 2011 (Portuguese), http://www.censo2010. ibge.gov.br/sinopse/index.php?dados=10&uf=00
7. Shepard C. W., Finelli L., Alter M. J., Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 2005 5 9 558 567 2-s2.0-23944506014 10.1016/S1473-3099(05)70216-4 (Pubitemid 41196755)
8. World Hepatitis Alliance, Viral Hepatitis: Global Policy 2010 London, UK World Hepatitis Alliance. http://www.worldhepatitisalliance.org/en/viral- hepatitis-global-policy-2010.html
9. Madhava V., Burgess C., Drucker E., Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infectious Diseases 2002 2 5 293 302 2-s2.0-0036234761 10.1016/S1473-3099(02)00264-5 (Pubitemid 34464740)
10. Te H. S., Jensen D. M., Epidemiology of hepatitis B and C viruses: a global overview. Clinics in Liver Disease 2010 14 1 1 21 2-s2.0-74549128529 10.1016/j.cld.2009.11.009
11. Public Health Agency of Canada, Epidemiology of Acute Hepatitis C Infection in Canada-Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) 2009 Ontario, Canada Public Health Agency of Canada. http://publications.gc.ca/collections/collection-2011/aspc-phac/ HP40-41-2010-eng.pdf
12. Centers for Disease Control and Prevention, Surveillance for Viral Hepatitis-United States, 2010 2010 Atlanta, Ga, USA Centers for Disease Control and Prevention. http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/PDFs/ 2010HepSurveillanceRpt.pdf
13. Armstrong G. L., Wasley A., Simard E. P., McQuillan G. M., Kuhnert W. L., Alter M. J., The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine 2006 144 10 705 714 2-s2.0-33646852746 (Pubitemid 46780630)
14. Dehesa-Violante M., Nuñez-Nateras R., Epidemiology of hepatitis virus B and C. Archives of Medical Research 2007 38 6 606 611 2-s2.0-34347363163 10.1016/j.arcmed.2007.03.001 (Pubitemid 47008933)
15. Kershenobich D., Razavi H. A., Sánchez-Avila J. F., Bessone F., Coelho H. S., Dagher L., Gonçales F. L., Quiroz J. F., Rodriguez-Perez F., Rosado B., Wallace C., Negro F., Silva M., Trends and projections of hepatitis C virus epidemiology in Latin America. Liver International 2011 31 2 18 29 2-s2.0-79958761330 10.1111/j.1478-3231.2011.02538.x
16. Sievert W., Altraif I., Razavi H. A., Abdo A., Ahmed E. A., Alomair A., Amarapurkar D., Chen C.-H., Dou X., El Khayat H., elShazly M., Esmat G., Guan R., Han K.-H., Koike K., Largen A., Mccaughan G., Mogawer S., Monis A., Nawaz A., Piratvisuth T., Sanai F. M., Sharara A. I., Sibbel S., Sood A., Suh D. J., Wallace C., Young K., Negro F., A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International 2011 31 2 61 80 2-s2.0-79958698124 10.1111/j.1478-3231.2011.02540.x
17. El-Zanaty F., Way A., Egypt Demographic and Health Survey, 2008 2009 Cairo, Egypt Ministry of Health and Population
18. Lavanchy D., The global burden of hepatitis C. Liver International 2009 29 1 74 81 2-s2.0-59149085501 10.1111/j.1478-3231.2008.01934.x
19. Frank C., Mohamed M. K., Strickland G. T., Lavanchy D., Arthur R. R., Magder L. S., El Khoby T., Abdel-Wahab Y., Aly Ohn E. S., Anwar W., Sallam I., The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. The Lancet 2000 355 9207 887 891 2-s2.0-0034635771 10.1016/S0140-6736(99)06527-7 (Pubitemid 30137669)
20. European Centre for Disease Prevention and Control, Annual Epidemiological Report 2011-Reporting on 2009 Surveillance Data and 2010 Epidemic Intelligence Data 2011 Stockholm, Sweden ECDC. http://ecdc.europa.eu/ en/publications/Publications/1111-SUR-Annual-Epidemiological-Report-on- Communicable-Diseases-in-Europe.pdf
21. Cornberg M., Razavi H. A., Alberti A., Bernasconi E., Buti M., Cooper C., Dalgard O., Dillion J. F., Flisiak R., Forns X., Frankova S., Goldis A., Goulis I., Halota W., Hunyady B., Lagging M., Largen A., Makara M., Manolakopoulos S., Marcellin P., Marinho R. T., Pol S., Poynard T., Puoti M., Sagalova O., Sibbel S., Simon K., Wallace C., Young K., Yurdaydin C., Zuckerman E., Negro F., Zeuzem S., A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International 2011 31 2 30 60 2-s2.0-79958748633 10.1111/j.1478-3231.2011.02539.x
22. Mukhopadhyaya A., Hepatitis C in India. Journal of Biosciences 2008 33 4 465 473 10.1007/s12038-008-0065-0
23. Nandi J., Bhawalkar V., Mody H., Elavia A., Desai P. K., Banerjee K., Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, Western India [4]. Vox Sanguinis 1994 67 4 406 407 2-s2.0-0027967780 (Pubitemid 24363014)
24. Jha J., Banerjee K., Arankalle V. A., A high prevalence of antibodies to hepatitis C virus among commercial plasma donors from western India. Journal of Viral Hepatitis 1995 2 5 257 260 2-s2.0-0029176571 (Pubitemid 3020489)
25. Tang S., Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China. Zhonghua Liu Xing Bing Xue Za Zhi 1993 14 5 271 274 2-s2.0-0027680233
26. Sy T., Jamal M. M., Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 2006 3 2 41 46 2-s2.0-33646238684
27. Mohd Hanafiah K., Groeger J., Flaxman A. D., Wiersma S. T., Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013 57 4 1333 1342 2-s2.0-84876149257 10.1002/hep.26141
28. Brazil Ministry of Health, Clinical Protocol and Therapeutic Guidelines for the Viral Hepatitis C and Coinfections 2011 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://bvsms.saude.gov.br/bvs/publicacoes/ protocolos-diretrizes-hepatite-viral-c-coinfeccoes.pdf
29. Brazil Ministry of Health, Supplement 2 of the Clinical Protocol and Therapeutic Guidelines for the Viral Hepatitis C and Coinfections-HCV Genotype 1 and Advanced Fibrosis 2013 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/ 49960/web-suplemento-2-protocolo-hepatite-c-pdf-98045.pdf
30. Brazil Ministry of Health, Manual for Capacity on Epidemiological Surveillance of Viral Hepatitis Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. 2008 (Portuguese), http://www.aids.gov.br/sites/default/files/cbve-hepatites.pdf
31. Paltanin L. F., Reiche E. M. V., Seroprevalence of anti-hepatitis C virus antibodies among blood donors, Brazil. Revista de Saude Publica 2002 36 4 393 399 2-s2.0-0036702683 (Pubitemid 35314685)
32. de Alencar Ximenes R. A., Pereira L. M. B., Martelli C. M. T., Merchán-Hamann E., Stein A. T., Figueiredo G. M., Braga M. C., Montarroyos U. R., Brasil L. M., Turchi M. D., da Fonseca J. C. F., de Lima M. L. C., de Alencar L. C. A., Costa M., Coral G., Moreira R. C., Cardoso M. R. A., Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cadernos de Saude Publica 2010 26 9 1693 1704 2-s2.0-78149435457
33. Brazil Ministry of Health, Epidemiological Bulletin on Viral Hepatitis Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. 2011 (Portuguese), http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/50073/ boletim-hepatites2011-pdf-64874.pdf
34. Universidade de Pernambuco, Núcleo de Pós- Graduação, Estudo de prevalência de base populacional das infecções pelos vírus das hepatites A, B E C nas capitais do Brasil 2010 (Portuguese) Pernambuco, Brazil Universidade de Pernambuco, Núcleo de Pós-Graduação. http://www.aids.gov.br/ sites/default/files/anexos/publicacao/2010/50071/estudo-prevalencia-hepatites- pdf-26830.pdf
35. Pereira L. M. M. B., Martelli C. M. T., Moreira R. C., Merchan-Hamman E., Stein A. T., Cardoso R. M. A., Figueiredo G. M., Montarroyos U. R., Braga C., Turchi M. D., Coral G., Crespo D., Lima M. L. C., Alencar L. C. A., Costa M., dos Santos A. A., Ximenes R. A. A., Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infectious Diseases 2013 13 1, article 60 2-s2.0-84873049178 10.1186/1471-2334-13-60
36. Victora C. G., Barreto M. L., Do Carmo Leal M., Monteiro C. A., Schmidt M. I., Paim J., Bastos F. I., Almeida C., Bahia L., Travassos C., Reichenheim M., Barros F. C., Health conditions and health-policy innovations in Brazil: the way forward. The Lancet 2011 377 9782 2042 2053 2-s2.0-79958765105 10.1016/S0140-6736(11)60055-X
37. Previsani N., Lavanchy D., Hepatitis C 2002 Geneva, Switzerland World Health Organization World Health Organization guide on Hepatitis C, WHO/CDS/CSR/LYO/2003. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/ en/index.html
38. European Association for the Study of the Liver, EASL Clinical Practice Guidelines: management of hepatitis C virus infection. Journal of Hepatology 2011 55 2 245 264 10.1016/j.jhep.2011.02.023
39. Mast E. E., Alter M. J., Margolis H. S., Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999 17 13-14 1730 1733 2-s2.0-0344959603 10.1016/S0264-410X(98)00415-0 (Pubitemid 29138908)
40. Centers for Disease Control, Prevention, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 1998 47 RR-19 1 33
41. do Livramento A., de Cordova C. M. M., Spada C., Treitinger A., Seroprevalence of hepatitis B and C infection markers among children and adolescents in the Southern Brazilian region. Revista do Instituto de Medicina Tropical de Sao Paulo 2011 53 1 13 17 2-s2.0-79953022720 10.1590/S0036- 46652011000100003
42. Scaraveli N. G., Passos A. M., Voigt A. R., do Livramento A., Tonial G., Treitinger A., Spada C., Seroprevalence of hepatitis b and hepatitis C markers in adolescents in Southern Brazil. Cadernos de Saude Publica 2011 27 4 753 758 2-s2.0-79957650797 10.1590/S0102-311X2011000400014
43. Averhoff F. M., Glass N., Holtzman D., Global burden of hepatitis C: considerations for healthcare providers in the United States. Clinical Infectious Diseases 2012 55 S10 S15 2-s2.0-84867308646 10.1093/cid/cis361
44. Thomas D., Zoulim F., New challenges in viral hepatitis. Gut 2012 61 supplement 1 i1 i5 2-s2.0-84860350134 10.1136/gutjnl-2012-302122
45. Dabbouseh N. M., Jensen D. M., Future therapies for chronic hepatitis C. Nature Reviews Gastroenterology and Hepatology 2013 10 5 268 276 2-s2.0-84877580639 10.1038/nrgastro.2013.17
46. Jacobson I. M., McHutchison J. G., Dusheiko G., Di Bisceglie A. M., Reddy K. R., Bzowej N. H., Marcellin P., Muir A. J., Ferenci P., Flisiak R., George J., Rizzetto M., Shouval D., Sola R., Terg R. A., Yoshida E. M., Adda N., Bengtsson L., Sankoh A. J., Kieffer T. L., George S., Kauffman R. S., Zeuzem S., Telaprevir for previously untreated chronic hepatitis C virus infection. New England Journal of Medicine 2011 364 25 2405 2416 2-s2.0-79959438789 10.1056/NEJMoa1012912
47. Poordad F., McCone J. Jr., Bacon B. R., Bruno S., Manns M. P., Sulkowski M. S., Jacobson I. M., Reddy K. R., Goodman Z. D., Boparai N., DiNubile M. J., Sniukiene V., Brass C. A., Albrecht J. K., Bronowicki J.-P., Boceprevir for untreated chronic HCV genotype 1 infection. New England Journal of Medicine 2011 364 13 1195 1206 2-s2.0-79953173221 10.1056/NEJMoa1010494
48. Bacon B. R., Gordon S. C., Lawitz E., Marcellin P., Vierling J. M., Zeuzem S., Poordad F., Goodman Z. D., Sings H. L., Boparai N., Burroughs M., Brass C. A., Albrecht J. K., Esteban R., Boceprevir for previously treated chronic HCV genotype 1 infection. New England Journal of Medicine 2011 364 13 1207 1217 2-s2.0-79953176289 10.1056/NEJMoa1009482
49. Zeuzem S., Andreone P., Pol S., Lawitz E., Diago M., Roberts S., Focaccia R., Younossi Z., Foster G. R., Horban A., Ferenci P., Nevens F., Müllhaupt B., Pockros P., Terg R., Shouval D., van Hoek B., Weiland O., van Heeswijk R., de Meyer S., Luo D., Boogaerts G., Polo R., Picchio G., Beumont M., Telaprevir for retreatment of HCV infection. New England Journal of Medicine 2011 364 25 2417 2428 2-s2.0-79959381354 10.1056/NEJMoa1013086
50. Maasoumy B., Port K., Markova A. A., Serrano B. C., Rogalska-Taranta M., Sollik L., Mix C., Kirschner J., Manns M. P., Wedemeyer H., Cornberg M., Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting. PLoS ONE 2013 8 2 2-s2.0-84873275651 10.1371/journal.pone.0055285 e55285
51. Hagan L. M., Schinazi R. F., Best strategies for global HCV eradication. Liver International 2013 33 1 68 79 2-s2.0-84872020388 10.1111/liv.12063
52. Brazil Ministry of Health, Departament: The Role of the Department 2013 Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/en/pagina/ departament
53. Brazil Ministry of Health, Hepatitis A, B, C, D and E for Communication Professionals Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. 2005 (Portuguese), http://bvsms.saude.gov.br/bvs/publicacoes/hepatites-abcde.pdf
54. Brazil Ministry of Health, Hepatites Virais no Brasil: Situação, Ações e Agenda 2011 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/sites/default/ files/anexos/publicacao/2011/50069/agendahepatites-2011-pdf-19532.pdf
55. Brazil Ministry of Health, Campaign for the 2011 World Hepatitis Day 2011 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/en/campanhas/2011/51680
56. Brazil Ministry of Health, Campanha do Dia Mundial de Luta Contra as Hepatites Virais 2012 2012 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/campanhas/2012/51811
57. Brazil Ministry of Health, A, B, C, D, E of Viral Hepatitis for Health Community Agents 2009 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/campanhas/2013/54905
58. Brazil Ministry of Health, Campaign for the 2013 World HepatItis Day 2011 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/campanhas/2013/54905
59. Brazil Ministry of Health, Health Services: Counselling and Testing Centres 2013 Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/ en/pagina/counselling-and-testing-centres
60. Brazil Ministry of Health, National (Unified) Health System Adopts Rapid Tests for Hepatitis B and C: Early Diagnosis Helps Prevent Disease Transmission and Enhances Efficacy of Treatment 2011 (Portuguese) Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. http://www.aids.gov.br/noticia/2011/sus-adota-testes- rapidos-para-hepatites-b-e-c (Portuguese)
61. Brazil Ministry of Health, Supplement 1 of the Clinical Protocol and Therapeutic Guidelines for the Viral Hepatitis C and Coinfections-Management of Patients Chronically Infected with HCV Genotype 1 and Advanced Fibrosis Brasília, Brazil Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Ministry of Health. 2013 (Portuguese), http://www.aids.gov.br/publicacao/2011/protocolo-clinico-e-diretrizes- terapeuticas-para-hepatite-viral-c-e-coinfeccoes
62. Ferreira A. D. S. P., Perez R. D. M., Ferraz M. L. G., Lewis-Ximenez L. L., Pereira J. L., de Almeida P. R. L., de Mattos A. A., Acute hepatitis C in Brazil: results of a national survey. Journal of Medical Virology 2011 83 10 1738 1743 2-s2.0-80051589771 10.1002/jmv.22175
63. Azevedo F. K. S. F. D., Azevedo C. C. S. F. D., Souto F. J. D., Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil. Memórias do Instituto Oswaldo Cruz 2012 107 2 217 223 2-s2.0-84875814306
64. Acras R. N., Pedroso M. L. A., Caum L. C., Pisani J. C., Amarante H. M. B. S., Carmes E. R., The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilian's Health Ministry is comparable to those reported in the literature. Arquivos de Gastroenterologia 2004 41 1 3 9 2-s2.0-4043154079 (Pubitemid 39071382)
65. Brandão C., Barone A., Carrilho F., Silva A., Patelli M., Caramori C., Focaccia R., Pereira L., Pedroso M., Tatsch F., Pessoa M., The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon -2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1. Journal of Viral Hepatitis 2006 13 8 552 559 2-s2.0-33746239298 10.1111/j.1365-2893.2006.00758.x (Pubitemid 44100407)
66. Silva G. F., Polônio R. J., Pardini M. I. M. C., Corvino S. M., Henriques R. M. S., Peres M. N., Silveira L. V. A., Coelho K. I. R., Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis C virus genotype 1: are nonresponders and relapsers different populations? Brazilian Journal of Infectious Diseases 2007 11 6 554 560 2-s2.0-41149092337 (Pubitemid 351425836)
67. de Almeida P. R. L., de Mattos A. A., Amaral K. M., Feltrin A. A., Zamin P., Tovo C. V., Picon P. D., Treatment of hepatitis c with peginterferon and ribavirin in a public health program. Hepato-Gastroenterology 2009 56 89 223 226 2-s2.0-64949130783
68. Narciso-Schiavon J. L., Schiavon L. D. L., Carvalho-Filho R. J., Sampaio J. P., Batah P. N. E., Barbosa D. V., Ferraz M. L. G., Silva A. E. B., Gender influence on treatment of chronic hepatitis C genotype 1. Revista da Sociedade Brasileira de Medicina Tropical 2010 43 3 217 223 2-s2.0-77954820842
69. Blatt C. R., Bernardo N. L. M. D. C., Rosa J. A., Bagatini F., Alexandre R. F., Balbinotto Neto G., Siebert U., Rocha Farias M., An estimate of the cost of hepatitis C treatment for the Brazilian health system. Value in Health Regional Issues 2012 1 2 129 135 2-s2.0-84870916234 10.1016/j.vhri.2012.10.001
70. Voigt A. R., Neto M. S., Spada C., Treitinger A., Seroprevalence of hepatitis b and hepatitis C markers among children and adolescents in the south brazilian region-metropolitan area of Florianópolis, Santa Catarina. Brazilian Journal of Infectious Diseases 2010 14 1 60 65 2-s2.0-77954811550
71. de Almeida M. K. C., dos Santos K. N., Fecury A. A., de Oliveira C. S. F., Freitas A. S., Quaresma J. A. S., Fuzii H. T., Martins L. C., Prevalence of viral hepatitis B and C in riverside communities of the Tucuruí Dam, Pará Brazil. Journal of Medical Virology 2012 84 12 1907 1912 2-s2.0-84867718668 10.1002/jmv.23356
72. Passos A. M., Neto M. S., Treitinger A., Spada C., Seroprevalence of HBV and HCV markers among young adult males in the air force in Florianó polis, South Brazil. Brazilian Journal of Pharmaceutical Sciences 2012 48 2 257 264 2-s2.0-84867710748 10.1590/S1984-82502012000200009
73. Aquino J. A., Pegado K. A., Barros L. P., Machado L. F. A., Seroprevalence of hepatitis B virus and hepatitis C virus infections among individuals in the State of Pará Revista da Sociedade Brasileira de Medicina Tropical 2008 41 4 334 337 2-s2.0-56049096545 10.1590/S0037- 86822008000400003
74. Garcia F. B., Pereira G. D. A., Martins P. R. J., Moraes-Souza H., Epidemiological profile of hepatitis C in blood donors at the Uberaba Regional Blood center. Revista da Sociedade Brasileira de Medicina Tropical 2009 42 1 1 4 2-s2.0-63049137159 10.1590/S0037-86822009000100001
75. Nascimento M. C., Mayaud P., Sabino E. C., Torres K. L., Franceschi S., Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. Journal of Medical Virology 2008 80 1 53 57 2-s2.0-36849015049 10.1002/jmv.21046 (Pubitemid 350220088)
76. Andrade A. F. B., Oliveira-Silva M., Silva S. G. C., Motta I. J. F., Bonvicino C. R., Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Memorias do Instituto Oswaldo Cruz 2006 101 6 673 676 2-s2.0-33749652108 (Pubitemid 44555614)